CEMPACA Trademark

Trademark Overview

On Wednesday, July 2, 2014, a trademark application was filed for CEMPACA with the United States Patent and Trademark Office. The USPTO has given the CEMPACA trademark a serial number of 86326448. The federal status of this trademark filing is REGISTERED as of Tuesday, May 22, 2018. This trademark is owned by Glaxo Group Limited. The CEMPACA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
cempaca

General Information

Serial Number86326448
Word MarkCEMPACA
Filing DateWednesday, July 2, 2014
Status700 - REGISTERED
Status DateTuesday, May 22, 2018
Registration Number5472370
Registration DateTuesday, May 22, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 6, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 10, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, May 22, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 22, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, March 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 6, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 16, 2018NOTICE OF ALLOWANCE CANCELLED
Friday, December 1, 2017PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Wednesday, November 29, 2017ASSIGNED TO PETITION STAFF
Wednesday, November 15, 2017TEAS PETITION TO AMEND BASIS RECEIVED
Saturday, July 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 30, 2017SOU EXTENSION 5 GRANTED
Wednesday, June 28, 2017SOU EXTENSION 5 FILED
Wednesday, June 28, 2017TEAS EXTENSION RECEIVED
Tuesday, December 13, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 10, 2016SOU EXTENSION 4 GRANTED
Tuesday, December 6, 2016SOU EXTENSION 4 FILED
Tuesday, December 6, 2016TEAS EXTENSION RECEIVED
Friday, July 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 14, 2016SOU EXTENSION 3 GRANTED
Wednesday, June 29, 2016SOU EXTENSION 3 FILED
Wednesday, June 29, 2016TEAS EXTENSION RECEIVED
Saturday, February 6, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 5, 2016SOU EXTENSION 2 GRANTED
Monday, December 21, 2015SOU EXTENSION 2 FILED
Thursday, February 4, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 21, 2015TEAS EXTENSION RECEIVED
Monday, June 22, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 1, 2015SOU EXTENSION 1 GRANTED
Monday, June 1, 2015SOU EXTENSION 1 FILED
Monday, June 1, 2015TEAS EXTENSION RECEIVED
Tuesday, January 13, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 18, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 18, 2014PUBLISHED FOR OPPOSITION
Wednesday, October 29, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, October 12, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 11, 2014ASSIGNED TO EXAMINER
Thursday, July 10, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 5, 2014NEW APPLICATION ENTERED

Related Keywords

cempaca pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological